The contract IDV award is a Federal Supply Schedule (FSS) contract 36F79723D004E held by Avedro, Inc., a subsidiary of Glaukos Corporation, to provide "DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS" to the U.S. Department of Veterans Affairs (VA). The contract is a multiple-award, civilian agency IDV with a $25,000.00 ceiling value and a period of performance ending on June 14, 2023. This interim agreement under the FSS Schedule 65 allows Avedro, Inc. to efficiently supply specialized ophthalmic products, such as PROS IMPLANTS and IDOSE TRAVOPROST 75MCG IMPLANTS, to various Veterans Integrated Service Networks (VISNs), including VISN 12, VISN 15, and VISN 19. The parent company, Glaukos Corporation, also holds a larger FSS contract (36F79723D0126) valued at $584,000.00 covering the same product categories, which further strengthens the company's position as a pre-approved supplier of advanced medical technologies and pharmaceutical solutions to the VA healthcare system. The scope of this contract IDV award and related task orders/delivery orders focuses on providing the VA with critical ophthalmic products and pharmaceutical solutions, particularly for the treatment and management of eye-related conditions among veterans. As a manufacturer of specialized medical devices and pharmaceuticals, Avedro, Inc. and its parent company Glaukos Corporation have established themselves as key suppliers to the federal healthcare market, demonstrating their ability to compete effectively for civilian agency contracts without the need for set-aside designations.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | $0 | 12/21/22 | |
| Not listed | Not listed | $0 | 12/5/22 |